{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:38:40Z","timestamp":1793306320164,"version":"4.5.0"},"reference-count":30,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["(FP\/2007-2013)\/ERC Grant Agreement no. 339239."],"award-info":[{"award-number":["(FP\/2007-2013)\/ERC Grant Agreement no. 339239."]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,8,29]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite simpler regimens than vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence (continuation of drugs) to direct oral anticoagulants are suboptimal, yet understudied in electronic health records (EHRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated (1) time trends at individual and system levels, and (2) the risk factors for and associations between adherence and persistence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In UK primary care EHR (The Health Information Network 2011\u20132016), we investigated adherence and persistence at 1\u2009year for oral anticoagulants (OACs) in adults with incident AF. Baseline characteristics were analysed by OAC and adherence\/persistence status. Risk factors for non-adherence and non-persistence were assessed using Cox and logistic regression. Patterns of adherence and persistence were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 36\u2009652 individuals with incident AF, cardiovascular comorbidities (median CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      VASc[Congestive heart failure, Hypertension, Age\u226575 years, Diabetes mellitus, Stroke, Vascular disease, Age 65-74 years, Sex category] 3) and polypharmacy (median number of drugs 6) were common. Adherence was 55.2% (95% CI 54.6 to 55.7), 51.2% (95% CI 50.6 to 51.8), 66.5% (95% CI 63.7 to 69.2), 63.1% (95% CI 61.8 to 64.4) and 64.7% (95% CI 63.2 to 66.1) for all OACs, VKA, dabigatran, rivaroxaban and apixaban. One-year persistence was 65.9% (95% CI 65.4 to 66.5), 63.4% (95% CI 62.8 to 64.0), 61.4% (95% CI 58.3 to 64.2), 72.3% (95% CI 70.9 to 73.7) and 78.7% (95% CI 77.1 to 80.1) for all OACs, VKA, dabigatran, rivaroxaban and apixaban. Risk of non-adherence and non-persistence increased over time at individual and system levels. Increasing comorbidity was associated with reduced risk of non-adherence and non-persistence across all OACs. Overall rates of \u2018primary non-adherence\u2019 (stopping after first prescription), \u2018non-adherent non-persistence\u2019 and \u2018persistent adherence\u2019 were 3.5%, 26.5% and 40.2%, differing across OACs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adherence and persistence to OACs are low at 1 year with heterogeneity across drugs and over time at individual and system levels. Better understanding of contributory factors will inform interventions to improve adherence and persistence across OACs in individuals and populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2019-315307","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T17:25:20Z","timestamp":1570728320000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":107,"title":["Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-3411","authenticated-orcid":false,"given":"Amitava","family":"Banerjee","sequence":"first","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"},{"name":"School of Health Sciences, University of Central Lancashire, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Benedetto","sequence":"additional","affiliation":[{"name":"Faculty of Health and Wellbeing, University of Central Lancashire, Preston, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gichuru","sequence":"additional","affiliation":[{"name":"Edge Hill University, Ormskirk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Burnell","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Central Lancashire, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Antoniou","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Schilling","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Barts and The London NIHR Cardiovascular Biomedical Research Unit and The William Harvey Research Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William David","family":"Strain","sequence":"additional","affiliation":[{"name":"Diabetes and Vascular Medicine Research, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Ryan","sequence":"additional","affiliation":[{"name":"Primary Care Clinical Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Watkins","sequence":"additional","affiliation":[{"name":"Faculty of Health and Wellbeing, University of Central Lancashire, Preston, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Marshall","sequence":"additional","affiliation":[{"name":"Primary Care Clinical Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J","family":"Sutton","sequence":"additional","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"2025092013174683000_106.2.119.1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gheart.2014.01.004","article-title":"Global burden of atrial fibrillation in developed and developing nations","volume":"9","author":"Chugh","year":"2014","journal-title":"Glob Heart"},{"key":"2025092013174683000_106.2.119.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530230025025"},{"key":"2025092013174683000_106.2.119.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"2025092013174683000_106.2.119.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"2025092013174683000_106.2.119.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"2025092013174683000_106.2.119.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907"},{"key":"2025092013174683000_106.2.119.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs446"},{"key":"2025092013174683000_106.2.119.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.022"},{"key":"2025092013174683000_106.2.119.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.001263"},{"key":"2025092013174683000_106.2.119.10","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31829b1d2a"},{"key":"2025092013174683000_106.2.119.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099276","article-title":"Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria","volume":"9","author":"Clemens","year":"2014","journal-title":"PLoS One"},{"key":"2025092013174683000_106.2.119.12","first-page":"440","article-title":"Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: real-world data from a population-based cohort","volume":"24","author":"Rodriguez-Bernal","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"2025092013174683000_106.2.119.13","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/pds.4272","article-title":"Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: applying a coherent framework to drug utilisation studies","volume":"26","author":"Mueller","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025092013174683000_106.2.119.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.793"},{"key":"2025092013174683000_106.2.119.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04167.x"},{"key":"2025092013174683000_106.2.119.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001117","article-title":"STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement","volume":"8","author":"Gallo","year":"2011","journal-title":"PLoS Med"},{"key":"2025092013174683000_106.2.119.17","first-page":"251","article-title":"Generalisability of the health improvement network (thin) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"2025092013174683000_106.2.119.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"2025092013174683000_106.2.119.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"2025092013174683000_106.2.119.20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1080\/03007995.2018.1477747","article-title":"A systematic literature review comparing methods for the measurement of patient persistence and adherence","volume":"34","author":"Forbes","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"2025092013174683000_106.2.119.21","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903126833"},{"key":"2025092013174683000_106.2.119.22","first-page":"113","article-title":"Non-persistence risk and health care resource utilization of Italian patients with non-valvular atrial fibrillation","volume":"109","author":"Cataldo","year":"2018","journal-title":"Recenti Prog Med"},{"key":"2025092013174683000_106.2.119.23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/PPA.S161151","article-title":"Primary nonadherence to chronic disease medications: a meta-analysis","volume":"12","author":"Lemstra","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"2025092013174683000_106.2.119.24","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/bcp.13299","article-title":"Trends in the prescription of novel oral anticoagulants in UK primary care","volume":"83","author":"Loo","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2025092013174683000_106.2.119.25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/phar.1989","article-title":"Real-World adherence and persistence with direct oral anticoagulants in adults with atrial fibrillation","volume":"37","author":"Manzoor","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2025092013174683000_106.2.119.26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/heart.89.6.687","article-title":"A rational basis for selection among drugs of the same class","volume":"89","author":"Brown","year":"2003","journal-title":"Heart"},{"key":"2025092013174683000_106.2.119.27","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-312977"},{"key":"2025092013174683000_106.2.119.28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2158","article-title":"Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010-2017","volume":"38","author":"Zhu","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2025092013174683000_106.2.119.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"key":"2025092013174683000_106.2.119.30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bcp.13797","article-title":"Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study","volume":"85","author":"Ofori-Asenso","year":"2019","journal-title":"Br J Clin Pharmacol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-315307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:17:54Z","timestamp":1758399474000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-315307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,12,24]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/heartjnl-2019-315307"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-315307","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]}}}